Pharmaceutical

NICE recommends Lilly’s tirzepatide to treat T2D

The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.

Sep 9, 2023 - 20:00
NICE recommends Lilly’s tirzepatide to treat T2D
The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.
Read the original article

Tags:

Previous Article

Otsuka and ShapeTX to develop gene therapies for eye diseases

Next Article

EC expands indication approval for Merck’s Ebola vaccine

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Zealand raises DKr1.45bn to advance obesity pipeline

Zealand raises DKr1.45bn to advance obesity pipeline

Jan 9, 2024

STAT+: Change Healthcare cyberattack outage could persist for weeks, UnitedHealth Group executive suggests

STAT+: Change Healthcare cyberattack outage could persi...

Feb 29, 2024

UK MHRA approves ViiV Healthcare’s cabotegravir formulations for HIV-1

UK MHRA approves ViiV Healthcare’s cabotegravir formula...

May 7, 2024